Trimetazidine
Back to searchMolecule Structure
Scientific Name
Trimetazidine
Description of the Drug
Trimetazidine is a piperazine derivative indicated as an adjunct therapy in symptomatic treatment of stable angina pectoris.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09069
http://www.drugbank.ca/drugs/DB09069
Brand Name(s)
Vastarel, Vastarel mr
Company Owner(s)
Not Available
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL230374 |
Human Metabolome Database | HMDB0259235 |
DrugBank | DB09069 |
PubChem: Thomson Pharma | 14799141 |
PubChem | 21109 |
Mcule | MCULE-9820869946 |
LINCS | LSM-5938 |
Nikkaji | J8.797A |
BindingDB | 80613 |
EPA CompTox Dashboard | DTXSID2048531 |
DrugCentral | 2750 |
Brenda | 143789 |
ChemicalBook | CB4126777 |
rxnorm | TRIMETAZIDINE |
ChEBI | 94789 |
ZINC | ZINC000019358638 |